Fraction of plasma exomeres and low-density lipoprotein cholesterol as a predictor of fatal outcome of COVID-19

• Published in: PloS one 2023-01, Vol.18 (2)
• Main Authors: Tatiana Usenko, Valentina Miroshnikova, Anastasia Bezrukova, Katerina Basharova, Sergey Landa, Zoia Korobova, Natalia Liubimova, Ivan Vlasov, Mikhael Nikolaev, Artem Izyumchenko, Elena Gavrilova, Irina Shlyk, Elena Chernitskaya, Yurii Kovalchuk, Petr Slominsky, Areg Totolian, Yurii Polushin, Sofya Pchelina
• Format: Article
• Language: English
• ISSN: 1932-6203

Transcriptomic analysis conducted by us previously revealed upregulation of genes involved in low-density lipoprotein particle receptor (LDLR) activity pathway in lethal COVID-19 caused by SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2). Last data suggested the possible role of extracellular vesicles in COVID-19 pathogenesis. The aim of the present study was to retrospectively evaluate parameters of cholesterol metabolism and newly identified EVs, exomeres, as possible predictors of fatal outcome of COVID-19 patients infected by the Alpha and the Delta variants of SARS-CoV-2 virus. Blood from 67 patients with severe COVID-19 were collected at the time of admission to the intensive care unit (ICU) and 7 days after admission to the ICU. After 30 days patients were divided into two subgroups according to outcome—34 non-survivors and 33 survivors. This study demonstrated that plasma low- and high-density lipoprotein cholesterol levels (LDL-C and HDL-C) were decreased in non-survivors compared to controls at the time of admission to the ICU. The conjoint fraction of exomeres and LDL particles measured by dynamic light scattering (DLS) was decreased in non-survivors infected by the Alpha and the Delta variants compared to survivors at the time of admission to the ICU. We first showed that reduction of exomeres fraction may be critical in fatal outcome of COVID-19.